Your Source for Multiple Myeloma Treatment in New Jersey

Multiple myeloma is cancer that affects certain white blood cells known as plasma cells that are in the immune system. Plasma cells produce antibodies—immune system proteins that assist the body in ridding itself of harmful substances. The body has many types of plasma cells, and, therefore, can respond to many types of substances. When cancer occurs, the body overproduces abnormal plasma cells known as myeloma cells.

Myeloma cells collect in the bone marrow and the outer layer of the bone. Because the cells begin in the blood plasma, myeloma is not a bone cancer, but is cancer that affects bones.

Multiple myeloma represents about 1 percent of all cancers in the United States, and about 22,000 Americans are diagnosed with it each year. This form of blood cancer is identified using x-rays, blood and urine tests, bone marrow aspiration and/or biopsy, skeletal survey, magnetic resonance imaging (MRI), computed tomography scan (also called a CT or CAT scan), or positron emission tomography (PET) scan.

We are proud to be an innovator in the diagnosis and treatment of multiple myeloma. Let us form a complete, customized care plan that prioritizes your needs and preferences, and puts you on the road to recovery.